India developing seven more COVID vaccines: Union Health Minister Harsh Vardhan

He said the Centre does not have any immediate plan to make the vaccines available in the open market and a decision will be taken as the situation demands.

Published: 06th February 2021 09:24 PM  |   Last Updated: 07th February 2021 10:42 AM   |  A+A-

Union Health Minister Harsh Vardhan

Union Health Minister Harsh Vardhan (Photo | PTI)

By PTI

KOLKATA: Union Health Minister Harsh Vardhan on Saturday said that the country is developing seven more COVID-19 vaccines and also working on further vaccine development to inoculate every citizen of India.

He said the Centre does not have any immediate plan to make the vaccines available in the open market and a decision will be taken as the situation demands.

The COVID-9 inoculation process for people aged above 50 will start in March, he told reporters.

"We are not dependent only on the two vaccines as the country is working on seven more indigenous vaccines."

"Simultaneously, we are also working on the development of more vaccines because India is a huge country and we need more players and research to reach out to everyone," he said.

Three of the vaccines are in the trial phase, two are in the pre-clinical stage, one is in phase 1 and another in phase 2, the Union health minister said.

"The COVID-19 inoculation process for people above 50 years of age will start next month," he said.

"Presently, COVID-19 vaccines are being administered on an emergency basis, under full observation and in a controlled manner. If the vaccines are released in the open market, there won't be any control over them. The decision will be taken as the situation demands," he added.

Two COVID vaccines Covishield and Covaxin are being administered to healthcare and the frontline workers during the ongoing initial stages of the inoculation process.

Covishield, AstraZeneca's COVID-19 vaccine, has been developed by the University of Oxford.

Covaxin is India's first indigenous COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV).


Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.